Cannabis Cultivar Collection Across Canada and the International Markets

Segra Enters Agreement to Offer Allele’s Proven Cannabis Cultivar Collection Across Canada and the International Markets

By /

VANCOUVER, (March 10, 2021) Segra International Corp. and Allele Genetics, a subsidiary of Catalyst BC, are pleased to announce they have entered into an exclusive agreement to distribute Allele’s collection of data-backed “Proven Cultivar” cannabis cultivars within the Canadian market and other legal international markets. Allele’s Proven Cultivars have been grown at both a commercial scale and for breeding and agronomic dataset development for over a decade by one of the most experienced operational teams in the industry, Catalyst BC, and its affiliates. Harnessing the strength of its proven Plant Tissue Culture technology, Segra will be releasing Allele cultivars on an ongoing basis as part of its Verified Clean Stock program.

Allele’s Proven Culticars have been carefully selected based on cannabinoid profile and yield, terpene profiles, and key characteristics such as maturation cycle time, high-density trichome area index (“TAI”), mold/mildew resistance and high bract-to-leaf ratios. The ongoing cultivar releases will represent abroad palate of terpene profiles yielding flavors and aromas ranging from citrus to berry and cake to gas–flavors the modern cannabis consumer desires. Amplifying Allele’s Proven Winners with the power of Segra’s tissue culture technologies will ensure consistently high-performing plants that are, as with all Segra tissue culture plants, Verified Clean Stock. Segra and Allele are confident that this offering will help producers turn better plants into better profits.

“Segra is thrilled to be partnering more closely with Allele and able to offer a portion of their data-backed collection, through tissue culture, to operators,” said Segra CEO Jamie Blundell. “Allele has developed an incredible portfolio of diverse, premium cannabis cultivars through tremendous industry expertise and experience. Partnering with top genetics consultants, like Allele Genetics, is central to Segra’s ability to continuously provide our clients with the cultivars of the future, and we are keen to showcase how top genetics, paired with the performance of tissue culture, will lead to operational optimization for Canadian LPs.”

“Today’s cannabis consumer desires potency, flavor, and aroma. Allele’s Proven Cultivars is a collective team effort to enhance and elevate the evolving consumer experience. We have spent the better part of a decade collecting critical agronomic data and consumer feedback necessary to drive cannabis cultivar identification, selection, collection, trialing, and optimization.” Said Eric Forington, Director of Plant Breeding and Genetics at Allele Genetics. Our primary goal is an emphasis on both consumer experience, through consistently high-quality, high-potency, flavor and aroma-forward flower, and LP success by allowing superior genetics to do the heavy agronomic lifting. We are incredibly excited to support the distribution of our Proven Cultivars in the Canadian and legal global import/export markets through Segra’s proprietary micropropagation process and look forward to partnering with Segra to provide true-to-type, commercially viable plantlets at scale.”

To learn more about this partnership and how Segra and Allele’s Tissue Culture plantlets can improve your output and reduce risk, please contact Segra at info@segra-intl.com.
 
About Allele:
 
Allele Genetics has been redefining the boundaries of high THC, high terpene cannabis breeding for over two decades and has consistently raised the bar for Top-Shelf cannabis genetics. Our breeding programs are focused on ultra-high cannabinoid content and selections from our award-winning genetics catalog consistently test over 30% THC. Allele Genetics combines over 20 years of traditional commercial cannabis breeding experience with the latest science and technology, including micro-propagation and molecular breeding tools, to enhance trait stability and provide genetic identification for our unique cannabis cultivars. Learn more about our team here.
 
About Segra:
 
Segra is an agriculture technology company offering plant tissue culture and DNA fingerprinting services to accelerate the advancement of the cannabis industry. The company’s proprietary technologies empower its clients to drive financial performance and mitigate risk while exploring the next frontier of optimized cultivation practices for the rapidly evolving cannabis consumer. Segra has developed industrial-scale laboratories to produce disease-free, robust, and DNA-fingerprinted cannabis plantlets for licensed producers globally. To support this vision, Segra has assembled a world-class team of specialists in the fields of agronomy, molecular genetics, plant tissue culture, and regulatory compliance. Learn more about Segra here.
 
For Further Information:
 
Carson Otto
 
Forward-Looking Information:
 
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan,” “continue,” “expect,” “project,” “intend,” “believe,” “anticipate,” “estimate,” “may,” “will,” “potential,” “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks, uncertainties, and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The company is under no obligation and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by applicable law.
 

Additional Resources

Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine

Testimonials and Public Relations

Latest Articles

  • Missouri Cannabis Licensing & Business Opportunities 2026
    Missouri has established itself as the premier success story for cannabis in the Midwest, evolving from a standard medical regime to a high-volume adult-use market that exceeded $1.52 billion in annual sales in 2025. As the market enters the 2026–2027 biennium, the landscape is shifting from rapid expansion toward operational maturation and specialized entry.
  • A large-scale, vertically integrated indoor cannabis cultivation and processing facility designed for North Carolina’s proposed "pharmaceutical-grade" medical market.
    North Carolina Cannabis Licensing & Business Opportunities 2026
    North Carolina remains one of the final significant jurisdictions in the United States without a comprehensive medical or adult-use cannabis program. However, the 2026–2027 biennium is projected to be the most consequential period in the state’s cannabis history. Driven by the formation of the North Carolina Advisory Council on Cannabis and an impending federal “hemp cliff,” the state is moving from a period of passive prohibition toward a structured, albeit highly restrictive, regulatory framework.
  • A high-tech, pharmaceutical-grade indoor cannabis cultivation facility in Nebraska designed for precision production under the state's strict 1,250-plant limit.
    Nebraska Cannabis Licensing & Business Opportunities 2026
    Nebraska is entering the 2026–2027 biennium at a historic crossroads. Following the 71% voter approval of Initiatives 437 and 438 in late 2024—the largest margin for a medical cannabis initiative in U.S. history—the state is currently standing up its first regulated medical infrastructure.
  • A massive, vertically integrated indoor cannabis cultivation and processing facility in Florida, designed to meet OMMU pharmaceutical-grade standards.
    Florida Cannabis Licensing & Business Opportunities 2026
    Florida represents the most capital-intensive and professionally structured cannabis market in the nation. As of 2026, the state is at a crossroads: it is both expanding its mature medical program and preparing for a potential constitutional shift toward universal adult-use access. On November 3, 2026, Florida voters will decide on the Marijuana Legalization Initiative (Amendment 3). Passing this requires a 60% supermajority—a high threshold, but one that polls suggest is within reach.
  • A large-scale indoor commercial cannabis cultivation facility in Virginia featuring tiered racking, advanced HVAC systems, and high-efficiency LED lighting.
    Virginia Cannabis Licensing & Business Opportunities 2026
    As Virginia transitions from its current “possession-only” model toward a fully regulated retail market, the 2026–2027 biennium represents a once-in-a-generation window for market entry. Unlike the vertically integrated “medical-only” regimes of the past, Virginia’s upcoming framework focuses on decentralization, specifically architected to favor small Virginia-based operators over large multi-state corporations.
  • A high-yield commercial cannabis cultivation facility in Minnesota featuring flowering plants under automated LED lighting and climate control.
    Minnesota Cannabis Licensing & Business Opportunities 2026
    Minnesota is currently undergoing a transformative shift in its cannabis landscape, moving from a semi-regulated hemp-derived market toward a fully comprehensive adult-use framework. Overseen by the Office of Cannabis Management (OCM), the 2026–2027 biennium represents the critical “enforcement phase” where temporary registrations sunset and permanent, merit-based licenses define the market’s long-term leaders.

Explore Our Articles

cannabis applications Cannabis Bar Cannabis Business Optmization cannabis careers Cannabis Compliance Cannabis Consumption Cannabis Consumption Bar Cannabis Inventory Management Systems Cannabis Investors cannabis jobs Cannabis Legalization cannabis licensing Cannabis Lounge cannabis marketing Cannabis Operational Procedures cannabis outreach Cannabis Regulations Cannabis Security Cannabis Software Cannabis Startup Cannabis Supply Chain Cannabis Technology Colorado controlled environment agriculture Cultivation cultivation facility Dispensary Design facility design Financial Planning HVAC HVACD Iowa Kansas Legal Update Legislation Medical Cannabis Minnesota Natural Medicine Nebraska New York Odor Control Oregon Psilocybin Psychedelics Recreational Cannabis

Scroll to Top